Hong, Xi et al. published their research in Organic Chemistry Frontiers in 2019 |CAS: 1268137-13-8

The Article related to halosuccinimide phenyl benzoxazole rhodium catalyst regioselective halogenation, halophenyl benzoxazole preparation, phenyl halo benzoxazole preparation, Heterocyclic Compounds (More Than One Hetero Atom): Other 5-Membered Rings, Two Or More Hetero Atoms and other aspects.Synthetic Route of 1268137-13-8

Hong, Xi; Zhou, Quan; Huang, Shuang; Cui, He-Zhen; Li, Zhi-Ming; Hou, Xiu-Feng published an article in 2019, the title of the article was Transition metal catalyzed C7 and ortho-selective halogenation of 2-arylbenzo[d]oxazoles.Synthetic Route of 1268137-13-8 And the article contains the following content:

A transition metal catalyzed chlorination, bromination and iodination of 2-arylbenzo[d]oxazole with N-halosuccinimide, in which ruthenium-catalyzed halogenation occurred on the C7-position and rhodium-catalyzed halogenation occurred on the ortho-position. The C7 halogenation was only observed for 5-methyl-2-(p-substituted)arylbenzo[d]oxazoles under rhodium catalysis. Preliminary mechanistic experiments and d. functional theory (DFT) calculations suggested that the C7-halogenation catalyzed by Ru might have a single-electron-transfer (SET) radical process, while the ortho-selective halogenation catalyzed by Rh proceeds probably through a redox-neutral SN2-type mechanism. The different selectivity of Rh catalyzed halogenation was due to the charge difference between benzo[d]oxazolyl and aryl rings. The two kinds of halogenated products were proved to be versatile by constructing aryl and alkynyl groups on the C-X site via Suzuki and Sonogashira cross-coupling reactions. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Synthetic Route of 1268137-13-8

The Article related to halosuccinimide phenyl benzoxazole rhodium catalyst regioselective halogenation, halophenyl benzoxazole preparation, phenyl halo benzoxazole preparation, Heterocyclic Compounds (More Than One Hetero Atom): Other 5-Membered Rings, Two Or More Hetero Atoms and other aspects.Synthetic Route of 1268137-13-8

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Ono, Masahiro et al. published their patent in 2016 |CAS: 1086378-35-9

The Article related to aromatic heterocycle preparation znf143 inhibitor, cancer treatment aromatic heterocycle znf143 inhibition, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Name: Methyl benzo[d]oxazole-7-carboxylate

On July 11, 2016, Ono, Masahiro; Kobayashi, Tsuneyuki; Yamazaki, Ryuta; Haibara, Hirotaka; Nishiyama, Yukiko; Hohashi, Atsuko; Nishiyama, Hiroyuki; Kurita, Akinari; Matsuzaki, Takeshi; Kono, Kimitoshi; Izumi, Hiroto published a patent.Name: Methyl benzo[d]oxazole-7-carboxylate The title of the patent was Preparation of heteroaryl compounds as ZNF143 inhibitors. And the patent contained the following:

Title compounds A-B-C-D [A = H, CH3, naphthalen-1-yl, etc.; B = -CC-; C = -CONH-, -CON(CH3)- or 1,3,4-oxadiazole-2,5-diyl; D = (un)substituted Ph or monocyclic heteroaryl containing N or S; or C and D may combine to form (un)substituted benzoxazol-2-yl, benzothiazol-2-yl, benzimidazol-2-yl, etc.; or salts thereof], useful for the treatment of cancer, were prepared For example, to a suspension of 3-phenylpropiolic acid (1.27 mmol) in CH2Cl2 (1.9 mL) were added oxalyl chloride (1.33 mmol) and DMF (1 drop), the resulting mixture was stirred at room temperature for 2 h and treated with 2-amino-4-chlorobenzonitrile (1.27 mmol) [room temperature, overnight] to give, after work-up, compound I (75.2% yield). The invention compounds, e.g., II, showed selective inhibition activity for ZNF143 over SV40 promotor. The experimental process involved the reaction of Methyl benzo[d]oxazole-7-carboxylate(cas: 1086378-35-9).Name: Methyl benzo[d]oxazole-7-carboxylate

The Article related to aromatic heterocycle preparation znf143 inhibitor, cancer treatment aromatic heterocycle znf143 inhibition, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazines and Quinoxalines (Including Piperazines) and other aspects.Name: Methyl benzo[d]oxazole-7-carboxylate

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Kim, Hyeong Seon et al. published their patent in 2019 |CAS: 1268137-13-8

The Article related to organic optoelectronic display device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Safety of 7-Bromo-2-phenylbenzo[d]oxazole

On January 7, 2019, Kim, Hyeong Seon; Shin, Chang Ju; Yoo, Eun Seon; Lee, Byeong Gwan; Jung, Ho Guk; Cho, Pyeong Seok; Lee, Sang Sin; Jung, Seong Hyeon published a patent.Safety of 7-Bromo-2-phenylbenzo[d]oxazole The title of the patent was Compounds for organic optoelectronic devices and display device comprising the same. And the patent contained the following:

A compound for organic optoelectronic device and a display device comprising the same having high-efficiency is provided. The compound is represented by formula 1, wherein T is a substituted or unsubstituted C2 to C30 heterocyclic group containing at least two nitrogen, L is a single bond, a substituted or unsubstituted C6 to C30 arylene group, a substituted or unsubstituted C2-C30 heteroarylene group, or its combination, X is oxygen or sulfur, Ar is a substituted or unsubstituted C6-C12 aryl group, R1-R4 each independently represent hydrogen, deuterium, a substituted or unsubstituted C1-C20 alkyl group, a substituted or unsubstituted C2-C20 alkenylene group, a substituted or unsubstituted C6-C20 aryl group, a substituted or unsubstituted C2-C30 heterocyclic group, or its combination, at least two of R1-R4 are connected to adjacent groups to form at least one substituted or unsubstituted aromatic ring or substituted or unsubstituted heteroaromatic ring, Ra is hydrogen, deuterium, a substituted or unsubstituted C1-C4 alkyl group, or a substituted or unsubstituted C6-C12 aryl group, Means that at least one hydrogen is substituted with deuterium, a C1-C10 alkyl group, a C6-C12 aryl group, or a C2-C10 heteroaryl group. Further, the compounds for an organic optoelectronic device is selected from the compounds represented in Group 1. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Safety of 7-Bromo-2-phenylbenzo[d]oxazole

The Article related to organic optoelectronic display device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Safety of 7-Bromo-2-phenylbenzo[d]oxazole

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Kim, Hyungsun et al. published their patent in 2015 |CAS: 1268137-13-8

The Article related to condensed cyclic compound organic light emitting device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole

On July 15, 2015, Kim, Hyungsun; Kim, Byungku; Kim, Youngkwon; Kim, Changwoo; Shin, Changju; Lee, Seungjae; Yu, Eunsun; Choi, Byoungki; Hwang, Kyuyoung published a patent.Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole The title of the patent was Condensed cyclic compounds and organic light-emitting devices including the same. And the patent contained the following:

The title condensed cyclic compound are I wherein L1, E1, R1, X11 to X13, X21 to X26, a1, b1 and c1 are described in the specification. An organic light-emitting device including such a compound is also disclosed. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole

The Article related to condensed cyclic compound organic light emitting device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Ahn, Hui Chun et al. published their patent in 2018 |CAS: 1268137-13-8

The Article related to electron buffer transport organic electroluminescent device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Computed Properties of 1268137-13-8

On March 21, 2018, Ahn, Hui Chun; Moon, Du Hyeon; Cho, Sang Hui published a patent.Computed Properties of 1268137-13-8 The title of the patent was Organic electroluminescent device comprising electron buffer layer and electron transport layer. And the patent contained the following:

The present invention relates to an organic electroluminescent device representing high efficiency and / or long life by including a specific combination of electronic buffer material and electron transport material. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Computed Properties of 1268137-13-8

The Article related to electron buffer transport organic electroluminescent device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Computed Properties of 1268137-13-8

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Ahn, Hee-Choon et al. published their patent in 2017 |CAS: 1268137-13-8

The Article related to electron buffering transport heterocyclic compound organic electroluminescent device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Related Products of 1268137-13-8

On May 4, 2017, Ahn, Hee-Choon; Cho, Sang-Hee published a patent.Related Products of 1268137-13-8 The title of the patent was Electron buffering materials, electron transport materials and organic electroluminescent device comprising the same. And the patent contained the following:

Electron buffering materials and electron transport materials are described by the general formula I (X1 = -N:, -NR7-, -O- or -S-; Y1 = -N:, -NR8-, -O- or -S- with the restriction that when X1 = -N:, Y1 = -NR8-, -O-, or -S-, when X1 = -NR7-, Y1 = -N:, -O- or -S-, X1 and Y1 may not both be -O- or -S-, and one of X1 and Y1 may not be -O- when the other is -S-; R1 = (un)substituted C6-30 aryl, or (un)substituted 3-30 membered heteroaryl; R2-4, R7, and R8 = independently selected H, D, halo, cyano, (un)substituted C1-30 alkyl, (un)substituted C6-30 aryl, (un)substituted 3-30 membered heteroaryl, etc.; b = 1 or 2; c = 1 or 2; and d = 1-4). Organic electroluminescent devices employing the materials are also described. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Related Products of 1268137-13-8

The Article related to electron buffering transport heterocyclic compound organic electroluminescent device, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Spectrometers and Optical Apparatus and other aspects.Related Products of 1268137-13-8

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Jung, Ho Yeong et al. published their patent in 2020 |CAS: 1268137-13-8

The Article related to fluorene derivative preparation organic electronic device material, Benzene, Its Derivatives, and Condensed Benzenoid Compounds: Dibenzocyclobutenes, Acenaphthenes, Fluorenes, and Their Benzo Analogs, Such As Fluoranthenes and other aspects.Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole

On October 6, 2020, Jung, Ho Yeong; Park, Yong Uk; Kim, Nam Su; Lee, Nam Geol published a patent.Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole The title of the patent was Preparation of fluorene derivatives as organic electronic device materials. And the patent contained the following:

Disclosed are compounds I [R1 – R4 are independently H, deuterium, tritium, halo, cyano, nitro, (un)substituted aryl, (un)substituted fluorenyl, (un)substituted heterocyclyl, (un)substituted alicyclyl, (un)substituted alkyl, (un)substituted alkenyl, (un)substituted alkynyl, (un)substituted alkoxy, (un)substituted aryloxy, or N-(L1-Ar1)(L2-Ar2); at least one of R1 and R2 is N-(L1-Ar1)(L2-Ar2) and R3 and R4 may combine together with adjacent groups to form a ring; a and b are independently 0-4; L1 and L2 are independently single bond, (un)substituted arylene, (un)substituted fluorenylene, (un)substituted heterocyclylene, or (un)substituted alicyclylene; Ar1 and Ar2 are independently (un)substituted aryl, (un)substituted fluorenyl, (un)substituted heterocyclyl, or (un)substituted alicyclyl]. Example compound II was prepared by palladium-catalyzed cross-coupling reaction of N,9-diphenyl-9H-fluoren-9-amine with bromobenzene in 88% yield. Electroluminescent device comprising an invention compound showed improvements in efficiency, driving voltage, and life span compared to device using previously reported compound The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole

The Article related to fluorene derivative preparation organic electronic device material, Benzene, Its Derivatives, and Condensed Benzenoid Compounds: Dibenzocyclobutenes, Acenaphthenes, Fluorenes, and Their Benzo Analogs, Such As Fluoranthenes and other aspects.Recommanded Product: 7-Bromo-2-phenylbenzo[d]oxazole

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Wu, Mingyue et al. published their research in Organic Letters in 2012 |CAS: 1268137-13-8

The Article related to nitrophenol benzylic alc iron oxidation reduction condensation dehydrogenation cascade, arylbenzoxazole preparation, oxidation reduction condensation dehydrogenation cascade catalyst iron dppf and other aspects.Product Details of 1268137-13-8

On June 1, 2012, Wu, Mingyue; Hu, Xiong; Liu, Juan; Liao, Yunfeng; Deng, Guo-Jun published an article.Product Details of 1268137-13-8 The title of the article was Iron-Catalyzed 2-Arylbenzoxazole Formation from o-Nitrophenols and Benzylic Alcohols. And the article contained the following:

The iron-catalyzed 2-arylbenzoxazole formation from o-nitrophenols and benzylic alcs. using hydrogen transfer is described. Various 2-arylbenzoxazoles were selectively obtained in good to excellent yields. The reaction tolerated a wide range of functionalities. The alc. oxidation, nitro reduction, condensation, and dehydrogenation were realized in a cascade without external reducing reagent and oxidant. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Product Details of 1268137-13-8

The Article related to nitrophenol benzylic alc iron oxidation reduction condensation dehydrogenation cascade, arylbenzoxazole preparation, oxidation reduction condensation dehydrogenation cascade catalyst iron dppf and other aspects.Product Details of 1268137-13-8

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Jie, liu et al. published their research in European Journal of Medicinal Chemistry in 2021 |CAS: 1268137-13-8

The Article related to trimethoxyphenylbenzoxazole preparation tubulin inhibitor antiproliferative sar, antiproliferative activities, apoptosis, cell cycle arrest, dual pde4/tubulin inhibitor, trimethoxyphenylbenzo[d]oxazole and other aspects.Category: benzoxazole

On November 15, 2021, Jie, liu; Ye, Wan; Xu, Jiang-Ping; Wang, Hai-Tao; Li, Xiao-Fang; Wang, Wen-Ya; Zhou, Zhong-Zhen published an article.Category: benzoxazole The title of the article was Discovery of novel trimethoxyphenylbenzo[d]oxazoles as dual tubulin/PDE4 inhibitors capable of inducing apoptosis at G2/M phase arrest in glioma and lung cancer cells. And the article contained the following:

To discover PDE4/tubulin dual inhibitors with novel skeleton structures, 7-trimethoxyphenylbenzo[d]oxazoles I [R1 = R2 = H, MeO; R3 = C6H5, 4-MeO-C6H4, 3-F-C6H4, etc] and 4-trimethoxyphenylbenzo[d]oxazoles II [R4 = C6H5, 3,4-MeO-C6H3, 4-F-C6H4, etc] were designed and synthesized by migrating the trimethoxyphenyl group of TH03 to the benzo[d]oxazole moiety. Among these compounds, approx. half of them displayed good antiproliferative activities against glioma (U251) and lung cancer (A549 and H460) cell lines. The structure-activity relationships of trimethoxyphenylbenzo[d]oxazoles led to the identification of I [R1 = H; R2 = MeO; R3 = 1H-indol-5-yl] bearing indol-5-yl side-chain as a novel dual PDE4/tubulin inhibitor, which exhibited satisfactory antiproliferative activities against glioma (IC50 = 300 ± 50 nM) and lung cancer (average IC50 = 39.5 nM) cells. Further investigations revealed that I [R1 = H; R2 = MeO; R3 = 1H-indol-5-yl] induced apoptosis at G2/M phase arrest and disrupted the microtubule network. The preliminary mechanism of action showed that I [R1 = H; R2 = MeO; R3 = 1H-indol-5-yl] down-regulated the expression of cyclin B1 and its upstream regulator gene cdc25C in A549. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Category: benzoxazole

The Article related to trimethoxyphenylbenzoxazole preparation tubulin inhibitor antiproliferative sar, antiproliferative activities, apoptosis, cell cycle arrest, dual pde4/tubulin inhibitor, trimethoxyphenylbenzo[d]oxazole and other aspects.Category: benzoxazole

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem

Lee, Ha-Rim et al. published their research in ACS Chemical Neuroscience in 2016 |CAS: 1268137-13-8

The Article related to benzothiazole derivative preparation structure activity astrocytogenesis stat3 smad erk, astrocytogenesis, differentiation, neural stem cells, neurodegeneration, neurological agents, structure−activity relationships and other aspects.Recommanded Product: 1268137-13-8

On January 20, 2016, Lee, Ha-Rim; Farhanullah; Lee, JiSoo; Jajoo, Rahul; Kong, Sun-Young; Shin, Jae-Yeon; Kim, Jae-Ouk; Lee, Jiyoun; Lee, Jeewoo; Kim, Hyun-Jung published an article.Recommanded Product: 1268137-13-8 The title of the article was Discovery of a Small Molecule that Enhances Astrocytogenesis by Activation of STAT3, SMAD1/5/8, and ERK1/2 via Induction of Cytokines in Neural Stem Cells. And the article contained the following:

Identification of small mols. that direct neural stem cells (NSCs) into specific cell types would be helpful to understand the mol. mechanisms involved in regulation of NSC fate, and facilitate the development of therapeutic applications. In the current study, we developed and screened small mols. that can modulate the fate of NSCs that are derived from rat fetal cortex. Among these compounds, compounds 5 and 6 successfully differentiated NSCs into astrocytes and neurons, resp. Compound 5 induced astrocytogenesis by increasing expression of interleukin-6, bone morphogenetic protein 2 and leukemia inhibitory factor and through consequent phosphorylation of signal transducer and activator of transcription 3 and Sma- and Mad-related protein 1/5/8 in NSCs. In addition, compound 5 increased the expression of fibroblast growth factor (FGF) 2 and FGF8 which may regulate the branching and morphol. of astrocytes. Taken together, our results suggest that these small mols. can serve as a useful tool to study cell fate determination in NSCs and be used as an inexpensive alternative to cytokines to study mechanisms of astrocytogenesis. The experimental process involved the reaction of 7-Bromo-2-phenylbenzo[d]oxazole(cas: 1268137-13-8).Recommanded Product: 1268137-13-8

The Article related to benzothiazole derivative preparation structure activity astrocytogenesis stat3 smad erk, astrocytogenesis, differentiation, neural stem cells, neurodegeneration, neurological agents, structure−activity relationships and other aspects.Recommanded Product: 1268137-13-8

Referemce:
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem